Treffer 1 - 10 von 10 für Suche 'Khedkar, Harshita', Suchdauer: 0,60s Treffer weiter einschränken
  1. 1
    mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2',4'-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications

    mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2',4'-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implicat... von Lawal, Bashir, Lee, Ching-Yu, Mokgautsi, Ntlotlang, Sumitra, Maryam Rachmawati, Khedkar, Harshita, Wu, Alexander T H, Huang, Hsu-Shan

    Veröffentlicht in Frontiers in oncology

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential GSK3β / β-Catenin / STAT3 / CD44 Suppressor with Anti-Glioblastoma Properties

    An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential GSK3β / β-Catenin / STAT3 / CD44 Suppressor with Anti-Glioblastoma Properties von Mokgautsi, Ntlotlang, Wen, Ya-Ting, Lawal, Bashir, Khedkar, Harshita, Sumitra, Maryam Rachmawati, Wu, Alexander T H, Huang, Hsu-Shan


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines

    Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines von Lawal, Bashir, Liu, Yen-Lin, Mokgautsi, Ntlotlang, Khedkar, Harshita, Sumitra, Maryam Rachmawati, Wu, Alexander T H, Huang, Hsu-Shan

    Veröffentlicht in Biomedicines

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    Multi-Omics Identification of Genetic Alterations in Head and Neck Squamous Cell Carcinoma and Therapeutic Efficacy of HNC018 as a Novel Multi-Target Agent for c-MET/STAT3/AKT Signaling Axis

    Multi-Omics Identification of Genetic Alterations in Head and Neck Squamous Cell Carcinoma and Therapeutic Efficacy of HNC018 as a Novel Multi-Target Agent for c-MET/STAT3/AKT Sign... von Khedkar, Harshita Nivrutti, Chen, Lung-Ching, Kuo, Yu-Cheng, Wu, Alexander T H, Huang, Hsu-Shan


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  5. 5
    In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1

    In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1 von Khedkar, Harshita Nivrutti, Wang, Yu-Chi, Yadav, Vijesh Kumar, Srivastava, Prateeti, Lawal, Bashir, Mokgautsi, Ntlotlang, Sumitra, Maryam Rachmawati, Wu, Alexander T. H., Huang, Hsu-Shan


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  6. 6
    Network Pharmacological Analysis through a Bioinformatics Approach of Novel NSC765600 and NSC765691 Compounds as Potential Inhibitors of CCND1/CDK4/PLK1/CD44 in Cancer Types

    Network Pharmacological Analysis through a Bioinformatics Approach of Novel NSC765600 and NSC765691 Compounds as Potential Inhibitors of CCND1/CDK4/PLK1/CD44 in Cancer Types von Mokgautsi, Ntlotlang, Wang, Yu-Chi, Lawal, Bashir, Khedkar, Harshita, Sumitra, Maryam Rachmawati, Wu, Alexander T. H., Huang, Hsu-Shan

    Veröffentlicht in Cancers

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  7. 7
    A preclinical report of a cobimetinib-inspired novel anticancer small-molecule scaffold of isoflavones, NSC777213, for targeting PI3K/AKT/mTOR/MEK in multiple cancers

    A preclinical report of a cobimetinib-inspired novel anticancer small-molecule scaffold of isoflavones, NSC777213, for targeting PI3K/AKT/mTOR/MEK in multiple cancers von Lawal, Bashir, Lo, Wen-Cheng, Mokgautsi, Ntlotlang, Sumitra, Maryam Rachmawati, Khedkar, Harshita, Wu, Alexander TH, Huang, Hsu-Shan


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  8. 8
    Deciphering the immuno-pathological role of FLT, and evaluation of a novel dual inhibitor of topoisomerases and mutant-FLT3 for treating leukemia

    Deciphering the immuno-pathological role of FLT, and evaluation of a novel dual inhibitor of topoisomerases and mutant-FLT3 for treating leukemia von Lawal, Bashir, Kuo, Yu-Cheng, Khedkar, Harshita, Mokgautsi, Ntlotlang, Sumitra, Maryam Rachmawati, Wu, Alexander Th, Huang, Hsu-Shan


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  9. 9
    Erratum: A preclinical report of a cobimetinib-inspired novel anticancer small-molecule scaffold of isoflavones, NSC777213, for targeting PI3K/AKT/mTOR/MEK in multiple cancers

    Erratum: A preclinical report of a cobimetinib-inspired novel anticancer small-molecule scaffold of isoflavones, NSC777213, for targeting PI3K/AKT/mTOR/MEK in multiple cancers von Lawal, Bashir, Lo, Wen-Cheng, Mokgautsi, Ntlotlang, Sumitra, Maryam Rachmawati, Khedkar, Harshita, Wu, Alexander Th, Huang, Hsu-Shan


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  10. 10
    A preclinical report of a cobimetinib-inspired novel anticancer small-molecule scaffold of isoflavones, NSC777213, for targeting PI3K/AKT/mTOR/MEK in multiple cancers

    A preclinical report of a cobimetinib-inspired novel anticancer small-molecule scaffold of isoflavones, NSC777213, for targeting PI3K/AKT/mTOR/MEK in multiple cancers von Lawal, Bashir, Lo, Wen-Cheng, Mokgautsi, Ntlotlang, Sumitra, Maryam Rachmawati, Khedkar, Harshita, Wu, Alexander TH, Huang, Hsu-Shan


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: